The economic and social impact of chronic brain disorders (CBD) such as Alzheimer’s disease (AD) and other neurodegenerative diseases will become the number one public-health problem worldwide, directly affecting 100 million people by 2050. On-going demographic trends, namely ageing populations worldwide, are leading to the unprecedented expansion of consumer demand for healthcare services. Healthcare systems worldwide soon will confront a serious crisis as a result of significant growth of the healthcare market, in a climate of shrinking resources.
Emerging Trends in Biomedicine and Health Technology Innovation
Addressing the Global Challenge of Alzheimer's
Policy paper
OECD Science, Technology and Industry Policy Papers
Share
Facebook
Twitter
LinkedIn
Abstract
In the same series
-
24 April 2024
-
20 November 2023